Human motor neuron diseases include hereditary spinal muscular atrophies of infants and children, and in adults, amyotrophic lateral sclerosis and the postpolio syndrome. Hereditary Canine Spinal Muscular Atrophy (HCSMA) is a dominantly inherited lower motor neuron disease which produces weakness, muscle atrophy, and paralysis. Clinically and pathologically it resembles the spinal muscular atrophies of infancy and childhood. Previous studies have focused on the pathologic changes in the spinal cord and proximal ventral roots and have not provided a satisfactory morphological basis for the profound weakness in affected individuals. Recent electrophysiological and morphological studies of individuals homozygous for HCSMA suggest that the clinical deficits may be related to abnormal conduction or degeneration in the distal portion of the motor axon or insufficient release of ACh at motor terminals or perhaps involvement of muscle itself, possibilities which have not been evaluated systematically to date. Several of these mechanisms have been suggested to play a role in the postpolio syndrome. The proposed studies will use intracellular recording and stimulation techniques to characterize further the nature and site of motor unit function deficits as the clinical course evolves. Complementary morphologic studies will use immunocytochemical and ultrastructural methods to determine the temporal evolution of the pathologic changes in the neuromuscular junction, distal axons, and skeletal muscle and compare them with electrophysiological data obtained on the same animals. The HCSMA model provides a unique opportunity to investigate an inherited motoneuron disease early in the disease while motoneurons are dysfunctional but viable and while secondary phenomena do not obscure the primary deficits.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS031621-01
Application #
3418563
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1993-09-15
Project End
1996-08-31
Budget Start
1993-09-15
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Carrasco, Dario I; Seburn, Kevin L; Pinter, Martin J (2016) Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp Neurol 275 Pt 1:172-81
Carrasco, Dario I; Bahr, Ben A; Seburn, Kevin L et al. (2016) Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease. Exp Neurol 278:116-26
Carrasco, Dario I; Bichler, Edyta K; Rich, Mark M et al. (2012) Motor terminal degeneration unaffected by activity changes in SOD1(G93A) mice; a possible role for glycolysis. Neurobiol Dis 48:132-40
Carrasco, Dario I; Bichler, Edyta K; Seburn, Kevin L et al. (2010) Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice. PLoS One 5:e9802
Green, S L; Westendorf, J M; Jaffe, H et al. (2005) Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease. J Comp Pathol 132:33-50
Carrasco, Dario I; Rich, Mark M; Wang, Qingbo et al. (2004) Activity-driven synaptic and axonal degeneration in canine motor neuron disease. J Neurophysiol 92:1175-81
Rich, Mark M; Wang, Xueyong; Cope, Timothy C et al. (2002) Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. J Neurophysiol 88:3305-14
Green, S L; Tolwani, R J; Varma, S et al. (2002) Structure, chromosomal location, and analysis of the canine Cu/Zn superoxide dismutase (SOD1) gene. J Hered 93:119-24
Rich, Mark M; Waldeck, Robert F; Cork, Linda C et al. (2002) Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease. J Neurophysiol 88:3293-304
Rich, M M; Pinter, M J (2001) Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 50:26-33

Showing the most recent 10 out of 17 publications